Vaccine-Vile-Syringe-ShotThe United Nations isn’t letting a good crisis go to waste, having recently endorsed the use of untested, experimental Ebola vaccines being rushed to market as this is typed. Agence France-Presse reports that the vaccines, which are bypassing the normal testing and approval process, should be ready in bulk by early 2015 for use in West Africa. Two vaccines in particular, one manufactured by British drug giant GlaxoSmithKline (GSK) and the other by U.S.-based NewLink Genetics, are being accelerated through clinical trials, according to World Health Organization (WHO) Assistant Director General Marie-Paule Kieny. If all goes as planned, the jabs will be available to health workers as early as November. “If everything goes well, we may be able to begin using some of these vaccines in some of the affected countries at the very beginning of next year,” stated Kieny to the media. More